Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Randomized Trial of Sedative Choice for Intubation
Vanderbilt University Medical Center
Chart Review of Patients Undergoing Ketamine Treatments for Depression
Sunnybrook Health Sciences Centre
Effect of Ketamine on BIS Values
University of Padova
The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation
Sheppard Pratt Health System
LSD Base and LSD Tartrate Bioequivalence and Bioavailability in Healthy Subjects
University Hospital, Basel, Switzerland
Evaluation of Psilocybin (TRP-8802) in the Treatment of Binge Eating Disorder
TRYP Therapeutics
Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care
Yvan Beaussant, MD, MSci
Frontline Clinician Psilocybin Study
University of Washington
Ketamine + Mindfulness for Depression
Rebecca Price
A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD
Perception Neuroscience
Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest
University of Milano Bicocca
Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept Trial
Definium Therapeutics US, Inc.
Effects of MDMA-like Substances in Healthy Subjects
University Hospital, Basel, Switzerland
Ketamine for the Treatment of Depression in Parkinson's Disease
Yale University
Psilocybin for Treatment-Resistant Depression
Brain and Cognition Discovery Foundation
Pre-post Evaluation of the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Repeated Blast Exposure
Stanford University
Effectiveness of Ketamine Administered by Mesotherapy in Complex Regional Pain Syndrome Type 1 (CRPS1)
Hospices Civils de Lyon
Stanford Regulating Circuits of the Brain Study - MDMA
Stanford University
Intranasal Ketamine in Ultra-REsistant Depression (SURE-ECT Non Responders)
Centre for Addiction and Mental Health
Synaptic Imaging and Network Activity in Treatment Resistant Depression
King's College London
Identification of a Safe and Non-Psychedelic Dose of Psilocybin
Diamond Therapeutics Inc.
Comparison of Nebulized Ketamine to Intravenous Sub-Dissociative Dose Ketamine for Pain
Antonios Likourezos
A Phase 2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder (PTSD)
Remedy
Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer
University of Utah
Low Dose Ketamine for Blunt Thoracic Trauma
North Memorial Health Care
Glutamate and Opioid Mechanisms of Antidepressant Response to Ketamine
King's College London
Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects
Beckley Psytech Limited
Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants
Supernus Pharmaceuticals, Inc.
Entheogen Resurgence
Vireo Health
Repeated Neurocognitive Measurements in Depressed Patients
Rebecca Price
Ketamine + Magnesium for Chronic Cluster Headache (KETALGIA)
University Hospital, Clermont-Ferrand
Ketamine As an Adjunctive Therapy for Major Depression (2)
University of Dublin, Trinity College
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
University Hospital, Basel, Switzerland
Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease
Joshua Woolley, MD, PhD
Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness
University Hospital, Basel, Switzerland
Repeat Dosing of Psilocybin in Migraine Headache
Yale University
Drug Effects on Interpersonal Interaction
University of Chicago
MDMA-Assisted Psychotherapy in Veterans With Combat-Related, Refractory PTSD
VA Loma Linda Health Care System
A Proof-of-Concept Trial on the Effect of Ketamine on Fatigue
National Institute of Nursing Research (NINR)
Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS
Novartis Pharmaceuticals
A Study of MELT-300 (Midazolam and Ketamine Sublingual Tablets) for Sedation and Intraoperative Ocular Analgesia in Participants Undergoing Cataract Extraction With Lens Replacement (CELR)
Melt Pharmaceuticals
Pharmacokinetics of GH001 in Healthy Volunteers
GH Research Ireland Limited
Psilocybin in Depression Resistant to Standard Treatments
King's College London
Effects of Dimethyltryptamine in Healthy Subjects
University Hospital, Basel, Switzerland
The Effect of Opioid-Free Anesthesia in TMJ Surgery
Massachusetts General Hospital
Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression
Central Institute of Mental Health, Mannheim
Effects of S-ketamine on Perioperative Opioid Consumption
Erasme University Hospital
Adding Trauma-focused Psychotherapy to Ketamine Treatment for Chronic PTSD
Icahn School of Medicine at Mount Sinai
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.